Clinical Report: NFIL3 as a Key Immune Regulator in Septic Cardiomyopathy

Overview

This study identifies NFIL3 as a critical immune regulator linked to hypoxia in septic cardiomyopathy (SCM). The findings suggest that NFIL3 may serve as a potential biomarker and therapeutic target for sepsis-related myocardial injury.

Background

Septic cardiomyopathy is a severe complication of sepsis, characterized by cardiac dysfunction and high mortality rates. Understanding the molecular mechanisms underlying SCM is essential for developing effective diagnostic and therapeutic strategies. This study highlights the role of hypoxia-driven immune dysregulation in SCM, emphasizing the need for targeted interventions.

Data Highlights

Key Findings

• Septic myocardium shows activation of hypoxia-related signaling pathways.
• NFIL3, TGM2, and SDC4 are key hypoxia-associated hub genes with diagnostic potential.
• Single-cell analysis reveals NFIL3 enrichment in macrophages during sepsis.
• In vivo and in vitro studies confirm upregulation of NFIL3 and HIF-1α in myocardial macrophages.
• NFIL3 plays a role in modulating macrophage inflammatory responses.

Clinical Implications

The identification of NFIL3 as a key regulator in SCM suggests its potential as a biomarker for early diagnosis and a target for therapeutic intervention. Understanding the immune landscape in septic myocardium may guide more effective treatment strategies for patients with sepsis-related cardiac dysfunction.

Conclusion

This study elucidates the role of NFIL3 in septic cardiomyopathy, linking hypoxia-driven immune dysregulation to cardiac injury. These insights pave the way for novel diagnostic and therapeutic approaches in managing sepsis and its cardiovascular complications.

References

1. Author(s)/Org, Source, Year -- Title
2. Author(s)/Org, Source, Year -- Title
3. Author(s)/Org, Source, Year -- Title
4. Surviving Sepsis Campaign Adult Guidelines | SCCM
5. No differences found between liberal or restrictive fluid treatment strategies for septic-induced hypotension | NHLBI, NIH
6. The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024 | Journal of Intensive Care
7. Basic Research in Cardiology — Raf Kinase Inhibitor Protein's Role in Myocardial Fibrosis During Increased Oxidative Stress Conditions
8. Surviving Sepsis Campaign Adult Guidelines | SCCM
9. Excessive HIF-1α driven by phospholipid metabolism causes septic cardiomyopathy through cytopathic hypoxia | Nature Cardiovascular Research
10. Unraveling the role of HIF-1α in sepsis: from pathophysiology to potential therapeutics—a narrative review | Critical Care
11. No differences found between liberal or restrictive fluid treatment strategies for septic-induced hypotension | NHLBI, NIH
12. The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024 | Journal of Intensive Care | Springer Nature Link
13. Landiolol for heart rate control in patients with septic shock and persistent tachycardia. A multicenter randomized clinical trial (Landi-SEP) | Intensive Care Medicine | Springer Nature Link
14. Checking your browser - reCAPTCHA
15. Ferroptosis and inflammation are modulated by the NFIL3-ACSL4 axis in sepsis associated-acute kidney injury | Cell Death Discovery